1 – 15 of 53
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
High-throughput molecular assays for inclusion in personalised oncology trials – State-of-the-art and beyond
(
- Contribution to journal › Article
-
Mark
Ketamine or ECT? What Have We Learned From the KetECT and ELEKT-D Trials?
(
- Contribution to journal › Article
-
Mark
Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Management of acute uncomplicated diverticulitis and adherence to current guidelines—a multicentre SNAPSHOT study
(
- Contribution to journal › Article
- 2023
-
Mark
Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers
(
- Contribution to journal › Article
-
Mark
Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Implementation of precision medicine in healthcare—A European perspective
(
- Contribution to journal › Scientific review
-
Mark
Precision cancer medicine : Concepts, current practice, and future developments
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Ventilation management and outcomes in out-of-hospital cardiac arrest : a protocol for a preplanned secondary analysis of the TTM2 trial
(
- Contribution to journal › Article
-
Mark
Trailblazing precision medicine in Europe : A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany
(
- Contribution to journal › Article
-
Mark
Therapist-guided and self-guided internet-delivered behavioural activation for adolescents with depression : a randomised feasibility trial
(
- Contribution to journal › Article
- 2021
-
Mark
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis : The UPSIDE study protocol
(
- Contribution to journal › Article
-
Mark
Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials
(
- Contribution to journal › Article
-
Mark
Current advances in digital cognitive assessment for preclinical Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Curcuma as an adjuvant in colorectal cancer treatment
(
- Contribution to journal › Article